Should Pharmacometrics Be Training the Next R&D President?GOBBURU, J. V. S.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 6, pp 579-580, issn 0009-9236, 2 p.Article

PopED: An extended, parallelized, nonlinear mixed effects models optimal design toolNYBERG, Joakim; UECKERT, Sebastian; STRÖMBERG, Eric A et al.Computer methods and programs in biomedicine (Print). 2012, Vol 108, Num 2, pp 789-805, issn 0169-2607, 17 p.Article

Pharmacometrics and systems biology in oncology: Is there an intersection?KLOFT, Charlotte.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 1, pp 89-90, issn 0946-1965, 2 p.Conference Paper

Dose finding by concentration-response versus dose-response: a simulation-based comparisonBERGES, Alienor; CHAO CHEN.European journal of clinical pharmacology. 2013, Vol 69, Num 7, pp 1391-1399, issn 0031-6970, 9 p.Article

Interpreting population pharmacokinetic-pharmacodynamic analyses -a clinical viewpointDUFFULL, Stephen B; WRIGHT, Daniel F. B; WINTER, Helen R et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 807-814, issn 0306-5251, 8 p.Article

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for RNEELY, Michael N; VAN GUILDER, Michael G; YAMADA, Walter M et al.Therapeutic drug monitoring. 2012, Vol 34, Num 4, pp 467-476, issn 0163-4356, 10 p.Article

An extremely strange observation on the equations for calculation of correlation coefficientGUANG WU.European journal of drug metabolism and pharmacokinetics. 2003, Vol 28, Num 2, pp 85-92, issn 0378-7966, 8 p.Article

Conditional Weighted Residuals (CWRES) : A Model Diagnostic for the FOCE MethodHOOKER, Andrew C; STAATZ, Christine E; KARISSON, Mats O et al.Pharmaceutical research. 2007, Vol 24, Num 12, pp 2187-2197, issn 0724-8741, 11 p.Article

Age and size are the major covariates for prediction of levobupivacaine clearance in childrenCHALKIADIS, George A; ANDERSON, Brian J.Paediatric anaesthesia (Paris). 2006, Vol 16, Num 3, pp 275-282, issn 1155-5645, 8 p.Article

The status of pharmacometrics in pregnancy: highlights from the 3^rd American conference on pharmacometricsCOEN VAN HASSELT, J. G; ANDREW, Marilee A; HEBERT, Mary F et al.British journal of clinical pharmacology. 2012, Vol 74, Num 6, pp 932-939, issn 0306-5251, 8 p.Article

Population Pharmacokinetics of Intermittent Vancomycin in Children with Cystic Fibrosis : VANCOMYCINSTOCKMANN, Chris; SHERWIN, Catherine M. T; ZOBELL, Jeffery T et al.Pharmacotherapy. 2013, Vol 33, Num 12, pp 1288-1296, issn 0277-0008, 9 p.Article

Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosineDORLO, Thomas P. C; BALASEGARAM, Manica; LIMA, María Angeles et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 8, pp 1996-2004, issn 0305-7453, 9 p.Article

A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgeryDANSIRIKUL, Chantaratsamon; LEHR, Thorsten; LIESENFELD, Karl-Heinz et al.Thrombosis and haemostasis. 2012, Vol 107, Num 4, pp 775-785, issn 0340-6245, 11 p.Article

Randomized exposure-controlled trials; impact of randomization and analysis strategiesKARLSSON, Kristin E; GRAHNEN, Anders; KARLSSON, Mats O et al.British journal of clinical pharmacology. 2007, Vol 64, Num 3, pp 266-277, issn 0306-5251, 12 p.Article

Patient adherence to prescribed antimicrobial drug dosing regimensVRIJENS, Bernard; URQUHART, John.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 5, pp 616-627, issn 0305-7453, 12 p.Article

Optimising piperacillin/tazobactam dosing in paediatricsTORNØE, Christoffer W; TWORZYANSKI, Jeffrey J; IMOISILI, Menfo A et al.International journal of antimicrobial agents. 2007, Vol 30, Num 4, pp 320-324, issn 0924-8579, 5 p.Article

Pharmacometric Characterization of Dabigatran HemodialysisLIESENFELD, Karl-Heinz; STAAB, Alexander; HÄRTTER, Sebastian et al.Clinical pharmacokinetics. 2013, Vol 52, Num 6, pp 453-462, issn 0312-5963, 10 p.Article

Comment optimiser et accélérer le développement clinique précoce? = How to optimize and accelerate early clinical development?KRUPKA, E.STP pharma pratiques. 2011, Vol 21, Num 5, pp 353-362, issn 1157-1497, 10 p.Conference Paper

Facilitating pharmacometric workflow with the metrumrg package for RBERGSMA, Timothy T; KNEBEL, William; FISHER, Jeannine et al.Computer methods and programs in biomedicine (Print). 2013, Vol 109, Num 1, pp 77-85, issn 0169-2607, 9 p.Article

Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young childrenBOUWMEESTER, N. J; ANDERSON, B. J; TIBBOEL, D et al.British Journal of Anaesthesia. 2004, Vol 92, Num 2, pp 208-217, issn 0007-0912, 10 p.Article

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithmsHAMBERG, Anna-Karin; FRIBERG, Lena E; HANSÉUS, Katarina et al.European journal of clinical pharmacology. 2013, Vol 69, Num 6, pp 1275-1283, issn 0031-6970, 9 p.Article

Pharmacometric Characterization of Efavirenz Developmental Pharmacokinetics and Pharmacogenetics in HIV-Infected ChildrenAHMED HAMED SALEM; FLETCHER, Courtney V; BRUNDAGE, Richard C et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 136-143, issn 0066-4804, 8 p.Article

Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576BURSI, Roberta; ERDEMLI, Gul; SHAHID, Mohammed et al.Psychopharmacologia. 2011, Vol 218, Num 4, pp 713-724, issn 0033-3158, 12 p.Article

Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulationPAULE, Ines; TOD, Michel; HENIN, Emilie et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 447-455, issn 0344-5704, 9 p.Article